Welcome to Synexus
Who We Are
Synexus is the world's largest site network, with more than 195 sites and
1,500 employees. We provide customers with access to more than 100 million
patients in key clinical development markets including Europe and the
United States.
Synexus offers biopharmaceutical and contract research organisations (CRO)
an unmatched capacity to find the right patient for the right trial at the right
time. Our global scale and world-class site network delivers unparalleled
capability, including data-driven site selection and activation, combined with
proven patient engagement and retention expertise across the U.S., Europe
and Africa.
Our network of Dedicated Research Sites allows customers to commission
global studies through a single contract with Synexus providing access to
more than 100 million patients from our global site footprint.
Customers then benefit from improved speed and efficiency in the trial
process, with high numbers of retained patients recruited from a smaller
number of sites, but also the reassurance of high quality data.
Patients respond to our community focused advertising. We tell them about
the clinical trial process so they can make an informed choice and remain
engaged throughout. Throughout we focus first and foremost on patient care
and safety. This is why Synexus continues to be the patient's choice for
clinical research, with a growing community of over 800,000 patients.
Employee Handbook SA
Version 6 - February 2018